Effective in high dosage
Vitamin B12 deficiency manifesting in maturation disorders of red blood cells and/or neurological disorders like funicular spinal disease (spinal cord lesion).
Vitamin B12 deficiency can be caused by long-term malnutrition and undernourishment (e.g. strong vegetarian diet), disturbed food intake, celiac diseases (e.g. sprue), fish tapeworm infection or blind loop syndrome or congenital dysfunction of vitamin B12 transport.
One tablet contains cyanocobalamin (vitamin B12) 1000 μg. Excipients: lactose, sucrose.Vitamine B12
In case of severe neurological symptoms and signs an initial parenteral administration is recommended.
Dosage depends on the pathology: For more detailed overview, please review the patient information leaflet.
The coated tablets should be taken in the morning on an empty stomach by swallowing them unchewed with some fluid.
The duration of administration, especially concerning the initial treatment in pernicious anaemia (generally 4 weeks), is the doctor’s decision. The duration is determined by the therapeutic response, which is why continuous monitoring is required. In proven pernicious anaemia, vitamin B12 must be substituted lifelong.
B12 Ankermann®.Active substance: Cyanocobalamin 1000 μg. Indications: Treatment of vitamin B12 deficiency states caused by malnutrition, treatment (maintenance therapy) of vitamin B12 deficiency states, e.g. as a result of impaired absorption of vitamin B12, permanent treatment of pernicious anaemia induced by vitamin B12 deficiency after normalisation of the blood values. Treatment of pernicious anaemia or neurological symptoms is initially parenteral until the blood values have normalised. The treatment of pernicious anaemia or neurological symptoms is initially carried out parenterally until the blood values normalise. B12 Ankermann® is used in adults. For risks and side effects, read the package leaflet and ask your doctor or pharmacist. Wörwag Pharma GmbH & Co. KG, 71034 Böblingen